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A B S T R A C T
Background: The effect of a pre-exercise meal as countermeasure to exercise induced immunodepression is
poorly known. Also, sedentary behavior is associated with increased cardiometabolic risk but studies on immune
changes are lacking. Therefore, we aimed to assess: 1) the impact of a pre-exercise Mediterranean meal (MdM)
compared with a fast-food type meal (FFM) on exercise-induced immunological changes and 2) the impact of an
induced acute period of sedentary behavior on neuro-immune-endocrine status.
Methods: /Design: This is a two steps clinical trial including: (a) randomized crossover clinical trial, comparing
the effect a high-fat/low-nutrient dense meal, FFM, with an isoenergetic similar high-nutrient dense meal, MdM,
in the immune response to an exercise challenge (EC) and (b) a pilot trial assessing the neuro-immune-endocrine
change induced by acute decreasing by half the usual physical activity level.
Results: A total of 46 participants (26 females), median aged 25 years were included. Of those 39-completed
protocol, including overweight, physical active and inactive and participants with asthma. There were no dif-
ferences in the EC between interventions. Dietary factors and physical activity were closely monitored during
interventions and kept similar. During physical inactivity induction, 31% reached the target of 50% reduction in
mean step number and 77% reached a 30% reduction.
Conclusion: The use of a pre-exercise meal to modulate immune response and the understanding of the im-
munological impact of physical inactivity might help to establish future recommendations on how to practice
exercise in a safer way and to recognize the potential impact of inactivity.
1. Introduction
Exercise modulates the inflammatory and immune response. Very
high and no or low training loads have been associated with higher risk
of illness [1]. Lymphocyte proliferation is suppressed by acute and re-
peated bouts of strenuous exercise [2]. A reduction in peripheral blood
Th1 cell number and production of interferon γ occurs in parallel with
an increase in blood Th2 and regulatory T-cells with prolonged and
exhaustive exercise [3]. Physical inactivity has been associated with an
increased low grade inflammation [4] and longer periods to im-
munodepression [5]. Therefore, a J-shaped relationship has been pro-
posed between absolute training load and illness, however this is not
applicable to all populations [1].
Response to a stressor, like strenuous exercise [6], depends on
several individual non-modifiable determinants such as genetic, gender,
physiologic and psychological history and changeable ones related with
individual fitness and nutritional status [7–10]. The dynamic process of
adjusting to perturbations of homeostasis is referred to as allostasis.
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Allostatic load is a complex clinical construct that takes in considera-
tion the repeated stress and wear-and-tear on the body and brain
[11,12]. Although much effort has been devoted to examining re-
sponses to physical activity changes, no holistic metric to measure se-
dentarism related immune dysfunction has been widely applied within
exercise physiology.
Nutritional strategies have been implemented as potential coun-
termeasures to exercise-induced immunodepression [7]. Dietary sup-
plements, namely carbohydrate ingestion have been associated with a
blunt of the inhibitory effects of exercise on T-cell proliferation and
neutrophil phagocytosis/oxidative burst activity [9,13]. N-3 poly-
unsaturated fatty acids (PUFA) supplementation has shown conflicting
results [14]. The intake of fruit and vegetables was correlated to an
increase of oxidative capacity [15]. Antioxidant vitamins, have shown
positive effects particularly in individuals that engage in repeated bouts
of vigorous exercise [7]. However, high doses and over-supplementa-
tion might diminish body's natural antioxidant defenses [7]. Few stu-
dies have address the potential additional benefit of using whole food
versus supplements in immune and health-related outcomes [16].
Mediterranean diet has antioxidant and anti-inflammatory proper-
ties [17]. Therefore, it could be used to modulate acute immune re-
sponse to exercise in a favorable direction in comparison to a Western
diet, which is characterized by high intake of saturated and trans fatty
acids, high glycemic load foods, and has low quantities of n-3 PUFA.
High glycemic and high fat meals have been correlated with post-
prandial lipemia and inflammation [18,19] and has been associated
with acute airway neutrophilic inflammation [20]. However, these
meals where never compared in their response to exercise response.
Accordingly, we hypothesized that (1) a pre-exercise Mediterranean
diet meal may induce a blunted immune and inflammatory response to
exercise, and (2) an induced sedentary behavior may increase the al-
lostatic load. Therefore, we aimed to assess in a randomized cross-over
trial the effects of two isoenergetic nutrient different meals (MdM vs
FFM) in the acute neuro-endocrine immune response to an exercise
challenge; followed by a pilot trial assessing the impact of an induced
short-term period of sedentarism on the allostatic load and immune
outcomes.
2. Methods
2.1. Study design
This is a two steps clinical trial including: (a) randomized crossover
clinical trial, comparing the effect a high fat micronutrient poor meal,
fast-food like meal (FFM) versus a isoenergetic similar, micronutrient
different, Mediterranean like meal (MdM) in the inflammatory and
immune response to an exercise challenge (Fig. 1) and (b) non-rando-
mized pilot trial assessing the impact of an induced physical activity
reduction, decreasing by half the mean step numbers per day, for two
weeks (Fig. 2).
A wash-out period of 7 days was performed between exercise
challenges, after which participants crossed over to the alternate diet
sequence. Study period length was selected in order to reach complete
normalization of post prandial inflammation and plasma lipid level
markers and to avoid carry-over of the exercise immune response, ac-
cordingly to previous published studies [18,21]. Baseline physical ac-
tivity and diet were assessed during the 7 days washing-out period.
Outcomes were evaluated before and after each meal; after exercise
challenge and after physical activity reduction.
This trial was registered in clinicaltrials.gov NCT02027675.
2.2. Participants
Subjects were invited to participate through trial posters bulletin
boards, newspapers, internet advertisements and during hospital visits.
All those with interest to participate completed a generic online
questionnaire that was linked to the online recruitment platform http://
meriitproject.weebly.com/, which included contact information details
and questioned age, height and weight and previous asthma reported
diagnosis. The flow chart of recruitment strategy is described in
Supplementary Fig. 1.
2.2.1. Inclusion and exclusion criteria
Subjects with asthma diagnosis, with excess of weight or obese, with
body mass index (BMI) ≥25kg/m2, or healthy with normal BMI
(18.5–24.9kg/m2) between 18 and 35 years old were eligible for par-
ticipation after providing informed consent.
Participants were excluded if they met any of the following criteria:
suffered from a respiratory disease other than asthma, except for severe
asthma according to GINA guidelines; had any major systemic diseases
(diabetes, cardiac arrhythmia, angina, congestive heart failure, ab-
normal electrocardiogram, renal or hepatic failure, mal-absorption
disease, intestinal inflammatory disease, chronic infectious diseases);
women who were breastfeeding, pregnant or intending to be pregnant;
subjects unable to comply with the study and follow-up procedures; had
dietary restrictions (ex. food allergy, vegetarians) or were on a weight
losing diet during the last 3 months before the study.
2.3. Randomization, allocation and blinding
Participants were randomly assigned to the intervention order in a
double-blinded fashion. A research assistant, generated the random
allocation of the meals sequence and assigned the subjects to the in-
tervention order, stratified by asthma diagnosis. This researcher was
not involved in the evaluation or intervention procedures. The research
nutritionist who prepared the meals was informed which meals to
prepare for that day, but was unaware of participant's allocation and
was not involved in the recruitment procedures or in the outcomes
evaluations. The investigator that performed exercise challenge was
also blinded for the intervention. The investigators that assessed the
outcomes were blinded to the participant's allocation order.
Participants were informed about the two different isoenergetic meals,
but were unaware until the study visit of the content of each the meals
or the order of the meals.
2.4. Study procedures
All participants performed a baseline visit. Then they would be
submitted to (a) randomized cross over trial that included two different
meals (FFM vs MdM) followed by an exercise challenges, each meal
separated by a wash out period of seven days and then (b) two weeks of
induced physical activity reduction. During the follow-up period they
were asked to maintain their dietary habits.
On the days of both interventions participants were requested to
have the same breakfast, at the same time, so that residuals from
breakfast could be minimized, avoiding coffee or caffeine containing
products; abstain smoking habits 12 h before the meal and during in-
tervention and alcohol ingestion during the preceding seven days.
The evaluations for outcomes and confounding factors were per-
formed before and after each meal and after each of the exercise
challenges, during wash-out period and at the end of the physical ac-
tivity reduction (Fig. 1, Table 1).
2.5. Interventions
2.5.1. Meal and exercise challenge
2.5.1.1. Fast food like and mediterranean like meal preparation and
analysis. Meals were chosen to be energetically similar and respecting
the Dietary Reference Intakes (DRI) for macronutrient distribution
[22]. Two different meal were performed one Fast Food (FFM) and
the other Mediterranean like meal (MdM). After each meal, participants
were not allowed to eat or drink, and could not perform any physical
D. Silva et al. Contemporary Clinical Trials Communications 10 (2018) 177–189
178
activity.
Fast food meal was acquired in a typical restaurant, contents and
nutritional composition were provided from the food manufacturer
database. For the development of MdM the main characteristics of a
Mediterranean dietary pattern were considered, and typical ingredients
were chosen, namely vegetables, bread and other whole grain cereals
(pasta), nuts, olive oil, cheese (as a dairy product), fish and fruits. MdM
was created to be energetically similar to the FFM and respecting DRI
for macronutrient distribution: carbohydrate 45–65% of total energy
value (TEV) (added sugars less than 25% of TEV), protein 10–35% of
TEV and fat 20–35% of TEV (polyunsaturated fatty acids 5–10%,
monounsaturated fatty acids 0.6–1.2%, cholesterol and saturated fatty
acids “as low as possible”) [23]. The MdM meal's nutritional composi-
tion was calculated according to information provided by Portuguese
Food Composition Table (National Health Institute Doutor Ricardo
Jorge, IP [24]). N-3 PUFA were estimated according to McCance &
Widdowson's Composition of Foods Integrated datase [25]. MdM was
prepared in an experimental kitchen by one independent investigator
and accordingly to a recipe (supplementary file 2). All ingredients were
rigorously weighted as confection cuisine; preparation methods were
Fig. 1. Study design of the interventional randomized cross over trial, participants allocation accordingly to intervention order and flow chart of trial participants.
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always the same. MdM contained a spinach and chickpea soup, whole
bread with fresh tomatoes, garlic and extra-virgin olive oil, whole pasta
mixed with olives, sardines and tomatoes with some fresh green salad
and as desert fresh fruit salad (apple, orange, and dry figs), and walnuts;
and water (40cl) as beverage. In Table 2 both meals composition are
specified. The Food Processor Plus program version SQL (ESHA Re-
search, Salem, OR, USA) was used to compare both meals composition,
in terms of energy and nutrient intakes and there were no significant
differences between meal nutritional composition and the calculated
version.
2.5.1.2. Exercise challenge. Three hours after each meal an exercise
challenge was performed and blood sample was obtained immediately
after the end of the challenge.
Progressive multistage exercise test, accordingly to Bruce Protocol
was performed in a treadmill until exhaustion [26]. During the chal-
lenge, heart rate was monitored. Participants were fitted with a tightly
sealing breathing mask connected to an airflow sensor. Ventilation and
respiratory gas analysis was measured via dynamic breath-by-breath
measurement using the Oxycon Pro Metabolic Cart, Jaeger™, Hochberg,
Germany, including breathing frequency (BF), oxygen consumption
(VO2) carbon dioxide production (VCO2), respiratory exchange ratio
(RER) and minute ventilation (VÈ) was performed.
2.5.2. Physical activity reduction
Participants were requested to reduce their mean steps per day by
half for two weeks. Number of daily steps were assessed using a ped-
ometer (Lifecorder Plus®) during the wash-out period, which was con-
sidered the run-in period for this intervention. Subjects were instructed
to wear the pedometer in the waistline above the knee, as previously
published [27], being removed only for sleep or other activity that
could damage the device, namely bath. Mean steps number per day
were calculated using the mean of number of steps per day performed
during the run-in period. Reduction was independent of the mean
number of steps performed per day.
During the two weeks of physical activity reduction participants
were advised to: take the elevators instead of the stairs and riding car
instead of walking or bicycling, reduce or stop daily exercise training.
They were also requested to maintain their usual dietary habits. Mean
number of steps reduction target was calculated using the performed
mean number of steps per day during the run-in period. Participants
could monitor their daily steps to access if they were following the
target step number. Accelerometer was used to evaluate physical ac-
tivity changes between the run-in period versus the reduced two weeks
of physical activity.
2.6. Study variables
2.6.1. Primary outcome and immune response outcomes
IL-6 is a pleiotropic cytokine [28,29], exercise-induced IL-6 is
modulated by nutritional interventions, therefore is the primary out-
come to evaluate the immune response of meal-exercise challenge and
physical activity reduction. It is further modulated by leukocyte and
lymphocyte subset response and other cytokines, which were also
measured and evaluated as immune response outcomes.
Peripheral blood lymphocyte subpopulations, including NK, B, T
and Treg relative numbers are determined to evaluate if different meals
modulate the response to exercise challenge and to address the acute
immune impact of induced short term physical activity reduction. For
exercise related inflammatory response [8,9], Treg related cytokine
response [30] and evaluation of immediate inflammatory response to
the different meals the following cytokines are evaluated: IL-6; TNF-α;
IL-8; IL-2; IL-10; TGF-β and IL1-RA.
Blood is obtained by venipuncture from an antecubital vein and
collected into two vacutainer tube containing EDTA, 7ml and two
Terumo Venosafe® serum-gel tubes 10ml.
Hematological parameters, total and differential leukocyte counts
are performed in an automated cell-counter. Two of the samples with
serum and plasma are centrifuged for 10min at 400× g and then
stored −80 °C. Lymphocyte subpopulations (including Treg cells) are
measured by flow cytometry. Venous blood samples are stained with
CD3-FITC, CD3-APC CD56-PE, CD45-PerCP-Cy5.5,CD19-APC,CD4-
FITC,CD8-PE (BD Biosciences®, San Jose, CA, USA) and CD16-PE.
Human Regulatory T Cell Cocktail and FoxP3-PE (BD Pharmingen®)
used for T regs cells evaluation. Samples are acquired on BD FACS
Calibur flow cytometer and analyzed using BD Infinicyt ™ software
version 1.7.
Immune response measured by cytokines is assessed by a bioassay
multiplex technology, based on Luminex xMAP®. This system uses
color-code microspheres with two fluorescent dyes. After an analyte
from a test sample is captured by the bead, a biotinylated detection
antibody is introduced. The reaction mixture is the incubated with
Streptavidin-PE conjugate, the reporter molecule, to complete the re-
action on the surface of each microsphere. The procedure performed in
Luminex 200™. Each individual microsphere is identified and the result
of its bioassay is quantified based on fluorescent reporter signals. IL-6,
TNF-α, IL-2 and IL 10 will be evaluated using Magnetic Luminex® Assay,
with a human premixed multi-analyte kit (LXSAHM-05, R&D systems®).
TGF β1 will be analyzed through ELISA by DRG®.
2.6.2. Secondary outcomes
Lung function was evaluated with spirometry measured by Spirolab®
Fig. 2. Study design of physical activity reduction.
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spirometer (MIR, Italy), with the WINSPIROPRO® software. Lung
function was performed at baseline, before and after each meal and 5,
10 and 15min after exercise challenge and after the period of physical
activity reduction. The procedure was carried out in the sitting position,
with participants wearing a nose clip. Lung function values included
forced expiratory volume in the first second (FEV1), forced vital capa-
city (FVC), forced expiratory flow between 25% and 75% of FVC
(FEF25–75%) and peak expiratory flow (PEF). Participants were asked to
inhale completely after three to four cycles of tidal breathing, and then
exhale with maximum force until no more air was expelled while
maintaining an upright posture. Throughout the procedure, loud verbal
encouragement was given to obtain the expiratory and inspiratory
manoeuvres completely with maximal effort. The procedure was mon-
itored for compliance by a researcher, and all tests were performed in
accordance with the acceptability and repeatability criteria according
to the American Thoracic Society criteria [31]. For lung function eva-
luation, the following parameters were used as outcomes: forced ex-
piratory volume in 1sec (FEV1) in L, FEV1% predicted, forced vital
capacity (FVC) in L, FVC% predicted, Maximum mid-expiratory flow
25–75% (MMEF25/75) in L and MMEF2575% predicted and FEV1/
FVC%. For comparing subgroups only % of predicted values of lung
function outcomes were used.
Airway inflammation was assessed by determining fraction of ex-
haled nitric oxide (FeNO) measured via electrochemical sensor
(NOBreath®, Bedfont Scientific, Kent, England). The test required that
participants exhale during 10 s at 50ml/s, with a minimum of 6 s pla-
teau achieved in the final of the manoeuvre. The mean of 3 measure-
ments were used to calculate final exhaled NO in parts per billion (ppb),
according to ATS/ERS recommendations [32,33].
Anthropometric measures Weight, height and waist circumference
were evaluated. Participants were lightly clothed and bare-footed.
Height was measured using a portable stadiometer (SECA® model 214).
Weight and body composition were measured using a digital scale
Tanita BC-418® (bioimpedance scale analysis). The percentage of body
fat and the fat-free mass were estimated with a four-electrode Tanita®.
Readings were performed before each of the meal-exercise challenges,
at the same time and after physical activity reduction and they were
obtained under controlled temperature and humidity conditions, with
the participant being shoeless.
Body mass index (BMI) was calculated as body weight divided by
square height (w/h2) and participants were classified according to
World Health Organization recommendations [34] in: underweight
(< 18.5Kg/m2), normal weight (18.5–24.9 kg/m2), overweight
(25.0–29.9 kg/m2) and obesity (≥30kg/m2). Waist circumference was
measured using a tape measure Seca model, accordingly to Interna-
tional Society for the Advancement of Kinanthropometry (ISAK) [35] to
the nearest 0.5 cm.
2.6.2.1. Allostatic load. Measurement of allostatic load is quantified by
the allostatic load score (ALS), which is used to measure the physiologic
response to stress [36]. The biomarkers included in allostatic load fall in
three categories [37,38]: (1) primary mediators include cortisol,
sympathetic and parasympathetic activity and pro and anti-
inflammatory cytokines and neuromodulators; (2) secondary
mediators, reflect the cumulative actions of primary mediators in
tissue/organ specific and represent abnormal metabolism and
cardiovascular risk, such as waist-hip ratio, blood pressure,
glycosylated hemoglobin, cholesterol, HDL; (3) tertiary outcomes are
actual diseases or disorders.
Due to the complexity and interdisciplinary index of personal and
public health, there is an issue of which biomarker panel best oper-
ationalizes AL. Therefore recently, computational modeling has been
use to optimize the ALS [39]. Biomarkers are mainly organized in five
physiological system, as previously reviewed by Juster et al. [40],
biomarkers from neuroendocrine system, cardiovascular and re-
spiratory; metabolic system, immune system and anthropometric status
(see Table 3).
There is a wide variability of biomarkers included and classifica-
tions [41]. Regarding the allostatic load scores, they will be divided
into sex-specific quartiles with high-risk (levels ≥75th percentile) de-
fined by the highest quartile for each variable except for HDL, which
used the lowest quartile (≤25 percentile) [41–43]. For each variable, a
dichotomous indicator will be created, reflecting those with “high-risk”
values (assigned a score of “1”) and “lower risk” values (assigned a
score of “0”). A total score of 18 will be used, a higher ALS indicates
worse stress associated physiologic dysfunction. An allostatic load over
3 is considered a high risk [44].
Table 2
Characterization of meals nutritional composition for both Mediterranean Meal
(MdM) and Fast Food Meal (FFM).
MdM FFM
Energy (kcal) 1070 1015
Protein (g) 45.0 31.0
Protein (% TEV) 16.8 12.2
Carbohydrates (g) 137.1 126.0
Carbohydrates (% TEV) 51.3 49.7
Sugars (g) 31.3 52.0
Sugars (% TEV) 11.7 20.5
Fiber (g) 23.0 7.0
Fiber (g% TEV) 4.3 1.4
Fat (g) 37.9 43.0
Fat (% TEV) 31.9 38.1
saturated (g) 7.4 12.0
saturated (% TEV) 6.2 9.3
MUFA (g) 12.2 NA
MUFA (% TEV) 10.3 NA
PUFA (g) 8.4 NA
n-3 (g) 4.0 NA
n-3 (% TEV) 3.4 NA
n-6 (g) 2.3 NA
n-6 (% TEV) 1.9 NA
Trans (g) 0.2 NA
Trans (%TEV) 0.17 NA
NaCl (g) 3.0 2.9
Vitamin A (retinol) (mcg REA) 386.5 NA
Vitamin C (mg) 50.7 NA
Vitamin E (mg) 5.3 NA
NA-not available; REA- Retinol equivalent activity; TEV-total energy value.
Table 3
Allostatic load biomarkers accordingly to the five-physiological system classi-
fication.
Biomarkers
Neuro-endocrine
Cortisol
Dehydroepiandrosterone (DHEA-S)
Epinephrine
Norepinephrine
Immune
High sensitivity C-reactive protein [mg/dl]
Metabolic
High density lipoprotein [mg/dl]
Low density lipoprotein[mg/dl]
Total cholesterol [mg/dl]
Triglycerides[mg/dl]
Glucose
Insulin
Cardiovascular and respiratory
Systolic blood pressure[mmhg]
Diastolic blood pressure[mmhg]
FEV1
Heart rate/pulse [bit/min]
Anthropometric
Body mass index
Fat-free Mass (kg)
Total body water (kg)
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High density lipoprotein (HDL), total cholesterol, triglycerides le-
vels, insulin, glycose, dehydroepiandroterone sulfate (DHEA-S) and
high sensitivity PCR are analyzed by ELISA technique. Low-density li-
poprotein (LDL) cholesterol estimated indirectly using Friedewald et al.
[45] formula.
2.6.2.2. Adipokine measurement. Adipocytes secrete adipokines which
functions include appetite and energy balance, insulin sensitivity and
lipid metabolism. These changes might modulate the response to an
exercise challenge accordingly to a specific meal content. Therefore, the
following evaluations are performed using a bioassay multiplex
technology, based on Luminex xMAP® with a human adipokine panel
that included Adiponectin, Resistin, PAI-1 (Total), Lipocalin-2/NGAL
and Adipsin, as previously described [46] using a human adipokine
panel (HADK1MAG-61 K, EMD Miillipore®). All samples are analyzed in
duplicates and measurements performed in serum.
2.6.2.3. Pupillometry. Autonomic nervous function is assessed by
pupillary activity parameters and rest heart rate, which has been
previously compared with heart rate variability outcomes with
promising results [47]. Pupillary measurements are performed with a
portable infrared PLR-200™ Pupillometer (NeurOptics Inc, CA, USA), as
previously published [48]. The subjects are asked to spend at least
15 min in a room to allow their eyes to adjust to the low lighting levels.
Two pairs of infrared-emitting diodes of an 880-nm wavelength
illuminate each eye and the measure was obtained 3 s after. At the
end of the measurement cycle, a graph of the pupil diameters as a
function of time was obtained for each eye and pupil light response
curves is recorded. The following parameters are obtained: the initial
pupil diameter (Init Dia) and at constriction peak (Min Dia), in
millimeters; the percent of the constriction; the time of the onset of
the constriction (latency), in seconds; the average and the maximum
constriction velocities (ACV and MCV respectively), and the dilation
velocity (ADV), all given in millimeters/second; and time at which
pupil has re-dilated 75% of the reflex amplitude (TM75%), in seconds.
Pupil diameters, latency, ACV, MCV, and the constriction amplitude are
related to parasympathetic activity, while ADV and T75 are measures of
sympathetic activity.
2.6.2.4. Primary and oxidative DNA damage. For oxidative stress
analysis, blood is cooled to approximately 4 °C with freeze packs.
Since the samples are not immediately analyzed after being processed
to cryopreserve the cells, an equal amount of a 20:80 (V/V) mixture of
dimethyl sulfoxide (DMSO) and Roswell Park Memorial Institute
Medium 1640 cell culture (RPMI) is added, and after that sample
aliquots are progressively frozen to −80 °C. The alkaline comet assay
is performed as described by Singh [49] with minor modifications to
detect basal levels of DNA damage (strand breaks, alkaline labile sites,
and transient repair sites). The assay is carried out with an additional
step of incubation with the restriction enzyme formamidopyrimidine
DNA-glycosylase (FPG) that can detect oxidized purines, including 8-
oxoGua, FaPyGua and 4,6-diamino-5-formamidopyrimidine (FaPyAde)
and other ring-opened purines.
2.6.2.5. Exhaled breath condensate breathprint, pH, sodium, potassium and
conductivity analysis. Exhaled breath condensate (EBC) is obtained by
cooling exhaled breath through contact with a cold surface or
condenser, accordingly to previous published guidelines [50–52]. This
is a non-invasive technique that requires tidal breathing, via a system of
exhaled air cooling. Participants breath through a special mouthpiece
with salivary trap and a single-way valve, a Disposable Collection
Circuit DECSS was used associated with a Peltier-type electric cooling
system, ECoScreen® Turbo, Carefusion®, wearing a nose clip.
Participants breath quietly, at tidal volume, for 15–20min. The
volume of condensate collected from exhaled volume was registered.
Immediately after collection, samples were stored in an inert material at
−80 °C.
pH measurement is performed before and after deaeration of the
samples for 10min using a handheld high resolution and accuracy de-
vice pHenomenal 1100H, VWR®, as previously published [51,52].
Sodium, potassium and conductivity in exhaled breath condensate. For
sodium and potassium, a battery-operated analyzer composed of a
control unit (meter) and a detachable sensor, which integrate the ion
selective electrode unit are used: B-722 LAQUAtwin® Horiba for sodium
and B-731 for potassium. These devices include a flat sensor and applies
the same test principle as standard laboratory electrodes. It has been
previously used in biological samples, sweat and urine, with an ex-
cellent relative and absolute reliability [53,54]. Evaluation of electro-
lyte in exhaled breath condensate has been previously performed in
various respiratory diseases, using other methodologies [55]. Con-
ductivity is evaluated using B-771 LAQUAtwin® Horiba, where it was
measured by the 2-AC bipolar method. In patients with sarcoidosis,
conductivity in exhaled breath condensate was significantly higher than
healthy controls [56].
Exhaled breath condensate breathprint analyzes (a) differences before
and after each meal and (b) before and after reducing physical activity.
For both experiments the Cyranose 320 (C-320, Sensigent) is used,
which is a hand-geld device capable of detecting smell prints through
the analysis of mixtures of VOCS. It is equipped with 32 chemical
sensors that respond differently to each mixture of VOCs through the
change in resistance of each chemical sensor. For the measurement with
the electronic nose 200 μl of the collected EBC is heated up to 37 °C.
Ambient air is used as reference air while baselining for 10 s. The snout
of the C-320 is hold above the surface drawing a sample for 10 s. Each
measurement with C-320 includes three steps: baseline, sensor is ex-
posed to reference air, sampling sensors are exposed to sample air and
purging the sensors are refreshed by exposing them to ambient air.
2.6.3. Potential confounding factors
Participants were evaluated at baseline with sociodemographic,
lifestyle habits questionnaire, including smoking and drinking habits, as
well as previous medical history. Furthermore, the following con-
founding factors were evaluated during the trial.
2.6.3.1. Dietary reports. Usual dietary intake was assessed by: (1) Food
Frequency questionnaire, validated for a Portuguese population [57], to
assess dietary intake in the previous 12 months; (2) dietary record
method, consisting on a record about all food and drinks consumed over
three consecutive days [58].
FFQ is a semiquantitative questionnaire, comprising 86 food items
or beverage categories and a frequency section with nine possible re-
sponses ranging from never to six or more times per day, and a seasonal
alternative. Blank lines were included to add any food that were not
listed. The portion size in grams was multiplied by the multiple/frac-
tion of daily frequency intake and by a seasonality variation factor for
each option selected, and dietary intake was estimated. The Food
Processor Plus program version SQL (ESHA Research, Salem, OR, USA),
supplemented with the Portuguese food-composition databases, was
used to convert food to energy and nutrient intakes.
Food consumption during the wash-out period was assessed using a
three-consecutive day food diary. Food portion sizes and beverages
consumed were estimated using household measures (cups, glasses,
spoons, slices, food wrappers, containers, etc.) as an aid in determining
serving sizes. A description of each food and beverage consumed was
recorded, including the method of preparation, the time it was eaten,
amounts (weight or portion sizes) and, if appropriate, the brand name
of the product. Nutrient analysis was performed using Food Processor,
complemented with Portuguese Food Composition Table [24].
2.6.3.2. Physical activity. Baseline physical activity was measured by
Baecke questionnaire validated for the Portuguese population [59,60].
It has 16 items with Likert-type response (from 1 to 5), designed to
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assess different categories of the broad concept of physical activity
(work/school, sport and leisure).
To evaluate changes in physical activity throughout the study a
short seven days self-administered version of International Physical
Activity Questionnaire (IPAQ-7) was also used and applied before the
intervention visits and after physical activity reduction intervention
[61]. IPAQ reports separately vigorous-intensity, moderate-intensity
and walking in terms of frequency and duration of each specific type of
activity, in the past 7 days and time spent sitting in an ordinary
weekday. IPAQ was expressed classified in three categories, low PA
level, moderate PA level and high PA, according to the guidelines for
data processing and analysis in as MET-min/week (metabolic equiva-
lent) [62].
Physical activity was also evaluated using a pedometer and accel-
erometer during the 7 days wash out-period and during the physical
activity reduction intervention. The accelerometer
(Actigraph®WGT3Xmonitor) was used on the right mid-axillary line of
the hip on an elastic belt or clip and wear during the study period, it
was only removed for sleep or any activity that could cause harm to
either the monitor or another person. Physical activity data was col-
lected by accelerometer in 60 s' epochs; a minimum of 8 h on at least 4
days were considered valid; 60min of consecutive zeros were con-
sidered invalid. Troiano 2008 [63] physical activity cut points were
used. Data was presented as average time spent in moderate and vig-
orous, light and sedentary physical activity per day.
2.6.3.3. Atopy. Skin prick tests with common aeroallergens
(Dermatophagoides pteronyssinus, grass pollen and weed pollen
mixture, cat and dog epithelium, Alternaria) with histamine and
saline as controls (Hal-allergy®) were performed. Atopy was defined
by the presence of positive skin prick tests with aeroallergen (≥3mm),
with adequate controls reaction accordingly to published guidelines
[64].
2.6.3.4. Asthma and rhinitis. Clinical asthma diagnosis was determined
at baseline, as well as asthma pattern, accordingly to Global Initiative
for Asthma recommendations [65]. Asthma stability was defined as no
exacerbation, respiratory tract infection, or oral corticosteroid in the
past 4 weeks. Those individuals under regular asthma treatment were
requested to maintain treatment as usual.
Lung function and airway responsiveness were evaluated with spiro-
metry (Spirobank, Winspiro pro software, MIR®) and carried out ac-
cording to the American Thoracic Society criteria reversibility was
evaluated 15min after 400 μg of salbutamol in aerochamber was ad-
ministered. Clinical significant reversibility was defined as a≥12% and
200ml increase in FEV1 after inhalation [66]. Presence of bronchodi-
lation response supported asthma diagnosis.
Rhinitis was diagnosed at baseline accordingly to the Allergic
Rhinitis and its impact on asthma guidelines [67]. Asthma and Rhinitis
control were evaluated by using Control of Allergic Rhinitis and Asthma
Test [68].
2.6.3.5. Cortisol, adrenaline and noradrenaline. Cortisol is performed in
serum sample using a solid phase enzyme-linked immunosorvent assay
(ELISA), based on the principle of competitive binding with the DRG
Cortisol ELISA Kit in the automatic ELISA Triturus analyzer. All samples
are analyzed in duplicates. Acute response to major physiological
systems to a single bout of exercise are usually proportional to the
exercise intensity. In endurance acute exercise response, the most
common and important change occur in adrenaline, cortisol and
insulin. As these changes might cause different immune response they
will be measured and addressed. Namely, insulin using multiplex
analysis technique and cortisol which will be evaluated by an
automated ELISA analyzer Triturus®. Levels of adrenaline and
noradrenaline are determined from plasma by ELISA. For these
measurements, blood samples are obtained in plasma-EDTA,
separated and frozen within 60min after the blood sample was taken.
2.7. Statistical analysis
All statistical analyses were performed using the SPSS 24.0 software
(Chicago, Ill) or STATA 15, accordingly to the statistical tests used.
Excel (Microsoft Office) and SPSS was used for data assembly and
graphical analysis. Normality of data distribution was assessed by the
Kolmogorov-Smirnov test, histogram and QQ plot distribution. Results
are expressed as median and inter-quartile range or mean and standard
deviation, as appropriate, and in discrete variables as count and per-
centage. Count and percentage were analyzed with Pearson-Chi Square
or Fisher exact test.
For comparison between groups, if a normal distribution was de-
scribed t-test-student would then be used in continuous variables, for
non-normal data, non-parametric tests, Mann-Whitney was used to
compare groups. Paired samples Wilcoxon signed rank test or paired
sample t-test were used as appropriate, particularly to compare changes
before and after physical activity reduction, meals and exercise chal-
lenge. The minimum threshold for statistical significance used was
p≤ 0.05. In data with skewed distributions, logarithmic transformation
was done and if appropriate (normal distribution is achieved) com-
parisons will be made with this change.
For the evaluation of the effect of the meals and exercise challenge
using the randomized cross-over an analysis by intention to treat will be
performed. Primary and secondary endpoints will be analyzed for the
presence of a carry-over effect [69]. For missing data, if missing com-
pletely at random (MCAR) was verified, a complete case analysis would
be done. Analysis for the presence of a carryover effect between in-
terventions was performed using a two-way mixed ANOVA, after nor-
malization of the study variables.
Mixed effect linear models, linear mixed model (LMM) or general-
ized linear mixed model (GLMM) will be used to evaluate the differ-
ences between interventions for primary and secondary outcomes, ad-
justed for confounders.
2.7.1. Sample size calculation
For the 2-intervention, 2-period cross over design part of the study,
estimates of between-subject variability have been derived from pre-
vious studies evaluating meal high carbohydrate ingestion [70]. Stan-
dard-deviation was estimated for interleukin-6, considering 5.3(1.9)
pg/ml in the intervention group vs 6.6(3.0)pg/ml in the placebo group,
the mean difference between groups was 1.30 with a 1.34 standard
deviation(sd). Another previous study evaluated a high fat challenge in
asthma and obese patients and showed an increase of IL-6 2 h after the
meal with a mean difference of 0.42 pg/ml with a standard deviation of
0.4 [20].
Estimates for sample size calculation were derived from cross-over
trial from Schoenfeld D. software [72], aiming to evaluate the sample
size for a cross-over study where the outcome is a measurement. As-
suming a mean difference of 0.8 pg/ml and a standard deviation of 0.8
for IL-6, in order to assess both exercise and meal challenge, a number
of 20 participants in each sequence would allow a power above 90% at
a 0.05 two tailed level of significance.
. To allow for dropouts the study was designed to recruit 25 parti-
cipants in each sequence. Regarding the evaluation of physical activity
reduction effect on other immune response, the absence of studies
evaluating the immunological outcomes precluded the power analysis.
Within subject's ANOVA will be used to adjust results for possible
confounders, namely the effect of age, gender, asthma and BMI.
2.7.2. Ethical consideration
This study was conducted in full conformity with the principles set
in the Declaration of Helsinki. The Ethics Committee of the University
of Porto approved the study, that is registered in clinicalTrials.gov ID
NCT02027675.
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3. Results
3.1. Baseline characteristics
A total of 46 subjects, median aged 25 years (26 females), were
included. During the trial, 5 participants withdraw before any of the
interventions, mainly due to unavailability to attend the visits. Two
participants dropped out before the second meal, a fast food meal, one
due to an adverse event, an ankle sprain not related with the study
intervention, nevertheless the participant was unable to attend and
complete the exercise challenge; the other participant due to commit-
ment issues. Accordingly, to the intervention order assignment, the
participants differed in gender, height and smoking habits, as described
in Table 4. Of those that consumed alcohol, there were no differences
between the allocation order (MdM then FFM 2.6[1.0; 5.2] vs FFM then
MDM 1.9[1.3; 3.2], p= 0.647).
For those participants with asthma and allergic rhinitis, median
value of CARAT score was 25 [23,29], and 58% had not well controlled
asthma (CARAT score ≤24).
3.2. Meal-exercise challenge
Exercise challenge lasted in median 15:22min with an interquartile
range of 13:46 to 16:43, the maximal oxygen uptake (VO2max) was
43.91ml/min/kg [38.3; 49.6] and anaerobic threshold median value
was 63.0% [56.0; 72.0], with no differences after FFM or MdM
(Table 5).
Values of VO2max obtained in both challenges, accordingly to
previous published reference values [73], corresponded to non-athletes
in 47% (n=21) of the participants (40.1 ml/min/kg [36.4; 45.7]), 35%
had levels above non-athletes reference values (48.5[45.0; 55.0]) and
10% had lower than normal values (33.0[32.2; 37.2]). Those with le-
vels above normal in maximal oxygen uptake had reported previous
high level of physical activity in the IPAQ score and, conversely, those
with under normal values had a low level of physical activity.
Using the Food processor, the FFM had slight more energy than the
MdM, nevertheless percentage of protein, carbohydrates and fat were
similar to what was previously calculated to build the meals (Table 2).
Table 4
Baseline characteristics and comparison accordingly to allocation for intervention order, Mediterranean and then Fast Food (MdM-FFM) or Fast food followed by
Mediterranean meal (FFM-MdM).
Total (n=46) MdM-FFM (n=20) FFM-MdM (n=26) p
Age years, median [IQR] 25 [22,30] 25 [21,30] 25 [22,30] 0.911‡
Female 26(57) 17(85) 9(35) 0.001§
Caucasian 43(94) 19(95) 24(92) 0.599§
Height in cm, median [IQR] 168[162; 178] 165[158; 171] 171[165; 180] 0.011‡
Weight in kg, median [IQR] 66.8 [58,77] 62,3 [5,8,54,71] 70.5 [2,7,60,82] 0.054‡
Waist circumference in cm, median [IQR] 77 [69,84] 74 [67,79] 81[71; 86] 0.085‡
Body mass index (BMI) 0.732§
Normal weight (18.5–24.9) 24(52) 10(50) 14(54)
Overweight (25–29.9) 17(37) 7(35) 10(39)
Obese (≥30) 5(11) 3(15) 2(8)
Smoking habits, active smokers 7(15) 6(30) 1(4) 0.014§
Alcohol consumption, n(%) 31(67) 14(70) 17(65) 0.553§
Atopy 32(70) 14(70) 18(69) 0.955§
Rhinitis diagnosis 19(41) 10(50) 9(35) 0.633§
Asthma diagnosis 13(28) 7(35) 6(23) 0.511§
FVC %prev, median [IQR] 103[96; 112] 103[94; 112] 103[98; 113] 0.657‡
FEV1 %prev, median [IQR] 103[93; 112] 101[93; 112] 103[93; 112] 1.000‡
FEV1/FVC %, median [IQR] 85.6[82.1; 90.1] 85.7[83.2; 90.8] 85.6[80.3; 88.6] 0.451‡
MMEF2575%prev, median [IQR] 94.0[72.5; 103.0] 94.0[77; 97.3] 95.0[68.8; 106] 0.748‡
FeNO,ppb, median [IQR] 29 [16,54] 28 [11,45] 30 [18,70] 0.276‡
IPAQ activity levels classification 0.521§
Low 23(50) 11(55) 12(46)
Moderate 5(11) 1(5) 4(15)
High 18(39) 8(40) 10(39)
Dietary Intake FFQ, median [IQR]
Energy kcal, median [IQR] 2352.5[1886.7; 2838.0] 2260.1[1494.2; 3177.1] 2364.1[2020.4; 2790.5] 0.909‡
Carbohydrates, % TEV, median[IQR] 46.8[42.4; 51.8] 44.9[41.9:47.9] 48.7[43.2; 53.2] 0.103‡
Protein, g, % TEV, median[IQR] 19.1[17.4; 21.5] 19.8[18.3; 21.8] 18.2[16.7; 21.2] 0.113‡
Lipids, g, % TEV, median[IQR] 34.4[31.7; 37.6] 35.4[32.7; 37.8] 33.3[31.5; 36.3] 0.135‡
Cholesterol, %TEV, median[IQR] 0.13[0.11; 0.17] 0.14[0.12; 0.17] 0.13[0.11; 0.15] 0.154‡
Saturated, % TEV, median[IQR] 9.8[8.8; 11.5] 10.0[8.2; 11.8] 9.7[8.9; 11.0] 0.713‡
Polyunsaturated, % TEV, median[IQR] 5.8[5.2; 6.8] 6.0[5.6; 6.8] 5.6[4.8:6.6] 0.141‡
Monounsaturated, % TEV, median[IQR] 15.0[13.5; 17.3] 15.0[13.5; 17.9] 14.9[13.4; 17.0] 0.629‡
Fiber, % TEV, median[IQR] 2.3[1.7; 2.7] 2.3[1.6; 2.9] 2.2[1.9; 2.6] 0.765‡
Data is presented as n(%), except if otherwise specified; IQR-interquartile range; TEV-total energetic value * A score ≥ 24 indicates good disease control;
‡Independent samples Mann-Whitney U test; § Qui-square test; ¤ Independent samples t-test.
Table 5
Exercise challenge evaluated outcomes after each of the meals Mediterranean
Meal (MDM) and Fast Food Meal (FFM).
MdM (n=41) FFM (n=39) pa
Duration, min 15:16[13:25; 16:57] 15:25[13:52; 16:40] 0.775
Time reached VO2 max,
min
14:05[13:08; 16:44] 14:35[13:20; 16:15] 0.472
Speed at VO2 max, km/h 6.8[6.7; 8.0] 6.8[6.7; 8.0] 0.778
Elevation at VO2 max 16.3[16.0; 18.0] 16.3[16.0; 18.0] 0.757
VCO2, ml/min 3301[2786; 4614] 3485[3009; 4510] 0.219
VO2, ml/min 2706[2364; 3945] 2967[2453; 3502] 0.558
VO2/kg, ml/min/kg 43.9[38.4; 49.8] 43.9[38.2; 49.6] 0.485
RER 1.2[1.2:1.3] 1.2[1.2:1.3] 0.155
Heart rate, bpm 188[182; 194] 190[185; 199] 0.001
Breathing frequency, per
min
51 [47,53] 51 [46,53] 0.911
Anaerobic treshold 64.5[57.3; 71] 63.0[53.3; 74] 0.426
VE 107[96; 142] 110[99:128] 0.889
a Wilcoxon signed rank.
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3.3. Changes in diet and physical activity during the wash-out period
Regarding dietary intake during the wash out period, those in-
dividuals which started with MdM food had a higher consumption of
saturated and monounsaturated fat in comparison with those that
started with FFM (Table 4). Levels of physical activity were assessed
during wash out both with accelerometer - 46.4min/day 95%CI [40.0;
52.8] of moderate vigorous physical activity - and using mean number
of steps per day: 9648 95% CI [8628; 106668]. IPAQ was used to
evaluate differences of behavior during wash-out and there was no
change between the two intervention visits, (2057 METS/min/day IQR
[920; 3832] first visit vs 2079 [750; 4031], p= 0.285.
There were no differences between FeNO before each meal (24
[16,47]) vs 27 [15,57], p= 0.472), even when patients were stratified
for asthma diagnosis.
3.4. Physical activity reduction
Sedentary behavior was induced for all the participants, using a
target level of mean steps per day that corresponded to half of the
number of steps per day performed during the wash-out week.
Evaluating both pedometer mean number of steps per day and mod-
erate vigorous physical activity there was a significant decrease in all
parameters (Table 6).
The global sedentary activity and daily average of sedentary bouts
also decreased, although this reduction was milder than the moderate
and vigorous physical activity. Twelve participants (31%) reached the
target level of mean steps reduction reducing by half or more than half
and 30 (77%) reached levels equal or higher than a 30% step reduction.
Two participants included in the trial were not able to reduce the mean
number of steps per day. Accordingly, to Tudor-Locke [74], pedometer-
determined physical activity cutoff points for healthy adults 10(22%)
had were “low active”, 13(28%) “somewhat active”, 11(24%) “active”
and 5(11%) “highly active”. Those that reduced lower than 30% the
number of steps per day were from the group that were “low active”
and “somewhat active”.
4. Discussion and conclusion
This clinical trial approaches the effects of two different meals, that
differ in micronutrients content, in the acute immune response to ex-
ercise challenge. This intervention was controlled not only for baseline
confounding factors, namely physical fitness and biological response to
stress, but also during the intervention with close monitoring of phy-
sical activity and dietary factors. Furthermore, an exploratory study
was designed to assess the immune and allostatic response to induced
sedentary behavior.
Our study has some potential limitations based on baseline parti-
cipant's characteristics that could have an impact on the interpretation
of the main outcomes and generalizability of the results. At first, con-
sidering the main inclusion criteria, both interventions cannot be gen-
eralized to other specific populations, namely those that are immune
depressed, elderly or children [75] our highly trained individuals. A
population bias related to the recruitment strategy may also occur, as
about a third of the included participants had values of maximal oxygen
uptake within the athlete levels during the exercise challenge. The ef-
fectiveness of recruitment strategies for adult participants to physical
activity interventions has been previously reported to be difficult, in
order to reach unhealthy or inactive participants, and when re-
presentative samples are obtained, lower participation rate was found
in previous studies [76]. The number of participants that completed
protocol did not reach the target of 20 participants in each arm, this
might limit the possibility to identify a difference in the main outcomes.
Nevertheless, our population sample size of 39 participants is one of the
largest reported to address nutritional intervention and IL-6 response to
exercise [28]. Despite including individuals that were overweight or
inactive, it is not possible to exclude that the participants had an in-
crease interest in a healthy life style than the general population. The
impact of this behavior was minimized by the exclusion of those par-
ticipants that were in the last 3 months on weight losing diet and/or
exercise programs and by doing a strict follow-up during the inter-
vention of physical activity, using objective measures like accel-
erometry and dietary registries. Finally, though we have recruited a
gender balanced population, there was an imbalance in gender alloca-
tion to the intervention order. This explains the difference both in
weight and height and could be avoided by gender stratification in
allocation. However using a cross-over design, where the same patient
performed both interventions, and the stability of this characteristic, it
is unlikely that this imbalance would affect the main outcomes eva-
luation. A high retention rate of 85% for the meal-exercise challenge
intervention was reached, when the long term physical activity reduc-
tion intervention was performed, only 31% could complete the targeted
50% reduction of mean steps number per day and 77% were able to
reach at least a 30% reduction.
The exploratory trial of induced sedentary behavior is limited by the
pre-post design. Nevertheless, this is, to our knowledge, the largest trial
evaluating the reduction of physical activity on immunological, in-
flammatory and allostatic load. Recently a trial protocol was published
that proposes to evaluate the usefulness of specific exercise strategies
during a step-reduction, but in an older population and using as a
primary outcome the muscle function and size [77]. The high attrition
rate was probably correlated to the included population, particularly
individuals which were “low active”. Previous studies have mainly fo-
cused on population that performed more than 10 000 steps per day and
in our sample, most of those that performed more than 10 000 steps
reached reductions higher than 50% in mean step number.
Regarding the outcomes used, they are mainly an in-vitro evalua-
tion. Nevertheless, in-vivo immediate impact of acute response to ex-
ercise is difficult to access and most of the studies are focused in long-
term impact of exercise [78]. In a recent study, a correlation with
specific lymphocyte subset profile, namely low naïve CD8+ T cell and
high T reg percentage with a reduced risk of respiratory viral infection
was observed [79]. Therefore, the evaluation of this surrogate out-
comes, as is included in our study protocol, might be indicative of a
potential immune susceptibility.
Our study has also important strengths. For the first time the effect
Table 6
Effect of the intervention in physical activity outcomes, comparison between usual and reduced physical activity (PA) period (n= 39).
Usual PA Reduced PA p*
Pedometer mean number of steps per day [95%CI] 9648[8628; 10668] 5870[5315; 6426] < 0.001
Physical activity (min/day MVPA), mean [95%CI] 46.4[40.0; 52.8] 24.7[20.0; 29.3] < 0.001
Sedentary activity min/day, mean [95%CI] 520.5[495.4; 545.6] 459.3[419.9; 498.7] 0.001
Light activity min/day, mean [95%CI] 272.7[253.1; 292.4] 217.9[199.2; 236.6] < 0.001
Daily average of sedentary bouts, median [IQR] 149.0 [103.0; 276.2] 130.0[101.5; 238.7] < 0.001#
IQR-interquartile range; MVPA minutes per day in moderate to vigorous physical activity; Paired sample t-test, except if otherwise specified # Wilcoxon Rank test.
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of a complete meal in the exercise induced immune response is studied.
This new line of investigation will have an important impact in the
population that will start or usually practices regular exercise training
and particularly for those in high level competition, who are particu-
larly prone to upper respiratory infection due to the described open
window theory [80]. The use of a balanced meal that potentially will
boost the immune system in a safe manner, without high doses of vi-
tamin supplements, will have an important impact on their health. In a
recent review, it was hypothesized that the use of a sufficient caloric
meal to meet energy requirements before and during exercise might
reduce both muscle-derived IL-6 immediately after exercise, mediated
by carbohydrate effects, and also the recovery levels of IL-6 serum re-
sponse through the action of ω-3 fatty acids and antioxidants [28]. A
meal that includes both interventions, as we are evaluating in our in-
tervention, might be of a potential additional benefit.
There are previous studies comparing the nutrigenomic effect of a
tocopherol-enriched Mediterranean versus a western high-fat meal,
which showed that oxidized-LDL measured 3 h after meal was sig-
nificantly higher with high fat meal versus the tocopherol enriched
meal (52.20 ± 9.50 versus 37.13 ± 5.68) and also an immediate up-
regulation of genes related to human inflammasome and oxidative
pathways were found [81]. Both meals were similar in calories content,
so it was hypothesized that the synergism of different nutrients, would
modulate the immune system and the Mediterranean meal exert a
protective action reducing LDL cholesterol oxidation through the in-
duction of antioxidant enzymes. Detrimental cardiovascular effects of
high fat or saturated meals have been shown promoting an increase of
metabolic syndrome associated outcomes [82], namely in endothelial
function [83] and post prandial lipemia [29]. In a recent study, airway
inflammation increased after a high fat meal when exercise was per-
formed in the postprandial period, both in exhaled NO and sputum
neutrophils, independently of the baseline physical activity level [84],
this supports an interaction between these two interventions and the
need to evaluate different meals response.
Previous studies regarding induced prolonged bed rest have proven
the concept that inactivity modulates immune response [5]. The effects
of induced sedentary behavior in endocrine outcomes were also re-
ported [85]. Changes in physical activity and acute physical inactivity,
frequently secondary to a lesion, will also potentially change the im-
mune response, particularly if participants have another inflammatory
disease like asthma. In summary, this study may provide an insight on
the neuro-endocrine, inflammatory and immune response changes after
acute exercise and inactivity, and help establish future recommenda-
tions on how to practice exercise in a safer way, reducing the risk of
immunodepression.
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